ASND

Q: What is the price of Ascendis Pharma (ASND) today?

The current price of Ascendis Pharma (ASND) is $ 218.06, representing a 27.67% gain over the past year. The stock began the year trading around $ 213.24 and is currently priced at $ 218.06. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Ascendis Pharma (ASND) pay dividends?

Ascendis Pharma (ASND) did not pay dividends over the past year.

Ascendis Pharma A/S

Price

$ 218.06

return (12m)

27.67%

p/e

23.64

p/bv

23.97

DIVIDEND YIELD

0.00%

ASND price

Ascendis Pharma

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ASND

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-9.33%

3 months

-5.61%

1 year

27.67%

2 years

70.84%

5 years

63.12%

10 years

1,460.92%

Fundamentals ASND

review the fundamentals of Ascendis Pharma shares

P/E

23.64

Sector: -3.80 Industry: -3.80

P/S (PSR)

13.41

Sector: -4.18 Industry: -4.18

P/BV

23.97

Sector: 1.92 Industry: 1.92

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

24.69%

Sector: -65.32% Industry: -65.32%

ROE

101.37%

Sector: -66.07% Industry: -66.07%

ROIC

0.00%

Sector: -2,920.39% Industry: -2,920.39%

NET MARGIN

56.74%

Sector: -40.34% Industry: -40.34%

GROSS MARGIN

89.05%

Sector: 36.85% Industry: 36.85%

OPERATING MARGIN

-1.18%

Sector: -39.20% Industry: -39.20%

EV/EBITDA

-1,182.83

Sector: -3.89 Industry: -3.89

EV/EBIT

-427.30

Sector: -3.98 Industry: -3.98

PRICE-TO-ASSETS

5.84

Sector: 1.42 Industry: 1.42

BVPS

9.10

Sector: 1.86 Industry: 1.86

EPS

9.22

Sector: -2.12 Industry: -2.12

EQUITY-TO-ASSETS RATIO

0.24

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.76

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

157.17%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF Ascendis Pharma ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current Price

$ 218.06

Fair Value

$ 43.45

Upside Return potential.

-80.07%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ASND

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	27.58	7.15	25.92%	2.18%	$ 580.26 B	21.83%
PFE	19.91	1.65	8.29%	6.56%	$ 149.16 B	11.83%
ABBV	110.89	-60.96	-54.98%	2.96%	$ 403.08 B	5.79%
NVO	65.46	40.20	61.41%	4.25%	$ 195.21 B	37.07%
MRK	32.94	6.41	19.45%	2.79%	$ 294.29 B	13.59%
AZN	26.65	5.84	21.93%	1.79%	$ 276.88 B	17.19%
GILD	16.93	6.66	39.33%	2.54%	$ 155.98 B	30.99%
BMY	16.00	5.79	36.19%	4.38%	$ 116.43 B	15.01%
ZTS	12.70	10.39	81.75%	2.59%	$ 33.58 B	27.79%
REGN	14.39	2.03	14.08%	0.59%	$ 63.66 B	29.65%
HALO	23.51	37.34	158.82%	0.00%	$ 8.20 B	23.13%
AMGN	24.59	20.87	84.87%	2.76%	$ 191.81 B	20.96%
MCK	20.09	-114.69	-570.98%	0.40%	$ 95.65 B	1.18%
HRMY	13.72	2.20	16.00%	0.00%	$ 2.00 B	16.20%
VRTX	26.05	5.84	22.41%	0.00%	$ 113.01 B	35.51%
CAH	33.83	-19.69	-58.20%	0.91%	$ 52.60 B	0.62%
ADMA	11.72	4.96	42.37%	0.00%	$ 1.94 B	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ASND Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Ascendis Pharma

Ascendis Pharma A/S

Average Investor10 user rating

4.0 (3 people)

United States

20 years

Founded: 2006

2015

Time since IPO - 11 years

482

Employees

Ascendis Pharma A/S (United States) is listed on the Nasdaq and has a market capitalization of $13.52 Billions, with shareholders equity totaling $564.13 Millions.

The company employs approximately 482 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Ascendis Pharma A/S reported $1.01 Billion in revenue, generating net income of $571.87 Millions.

Key financial metrics include a P/E ratio of 23.64, a price-to-book (P/B) ratio of 23.97, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ASND.

Market cap

$ 13.52 Billions

Net worth

$ 564.13 Millions

$ 564,130,000.00

Assets

$ 2.32 Billions

$ 2,315,930,000.00

Total Shares Outstanding

62.00 Millions

62,000,000

Average Daily Trading Volume

$ 687.32 Thousand

$ 687,320.00

Sector

Health Care

Industry

Biotechnology

ASND

ASND revenue and profits

Financial Results ASND

DRAG THE FRAME TO SEE MORE DATA

ASND cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 784.05 8,21% (12M)

P/E

20.09

0.40%

ROE

-570.98%

P/BV

-114.69

CAH - Cardinal Health

$ 223.85 40,59% (12M)

P/E

33.83

0.91%

ROE

-58.20%

P/BV

-19.69

JNJ - Johnson & Johnson

$ 240.87 57,17% (12M)

P/E

27.58

2.18%

ROE

25.92%

P/BV

7.15

MRK - Merck & Co.

$ 119.05 52,03% (12M)

P/E

32.94

2.79%

ROE

19.45%

P/BV

6.41

AZN - AstraZeneca

$ 178.75 23,65% (12M)

P/E

26.65

1.79%

ROE

21.93%

P/BV

5.84

ABBV - AbbVie

$ 227.73 22,97% (12M)

P/E

110.89

2.96%

ROE

-54.98%

P/BV

-60.96

PFE - Pfizer

$ 26.21 14,30% (12M)

P/E

19.91

6.56%

ROE

8.29%

P/BV

1.65

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 784.05 8,21% (12 M)

P/L

20.09

0.40%

ROE

-570.98%

P/VP

-114.69

CAH - Cardinal Health

$ 223.85 40,59% (12 M)

P/L

33.83

0.91%

ROE

-58.20%

P/VP

-19.69

JNJ - Johnson & Johnson

$ 240.87 57,17% (12 M)

P/L

27.58

2.18%

ROE

25.92%

P/VP

7.15

MRK - Merck & Co.

$ 119.05 52,03% (12 M)

P/L

32.94

2.79%

ROE

19.45%

P/VP

6.41

AZN - AstraZeneca

$ 178.75 23,65% (12 M)

P/L

26.65

1.79%

ROE

21.93%

P/VP

5.84

ABBV - AbbVie

$ 227.73 22,97% (12 M)

P/L

110.89

2.96%

ROE

-54.98%

P/VP

-60.96

PFE - Pfizer

$ 26.21 14,30% (12 M)

P/L

19.91

6.56%

ROE

8.29%

P/VP

1.65

Frequently Asked Questions

What is the price of Ascendis Pharma (ASND) today?

The current price of Ascendis Pharma (ASND) is $ 218.06, representing a 27.67% gain over the past year. The stock began the year trading around $ 213.24 and is currently priced at $ 218.06. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Ascendis Pharma (ASND) pay dividends?

Ascendis Pharma (ASND) did not pay dividends over the past year.

Is Ascendis Pharma (ASND) a good investment?

Ascendis Pharma (ASND) is currently trading at $ 218.06 with a P/E ratio of 23.64. This represents a -1,446% premium compared to its historical average P/E. Over the past year, the stock has gained 27.67 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 27.67%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Ascendis Pharma (ASND) stock?

You can buy Ascendis Pharma (ASND) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ASND and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Ascendis Pharma (ASND) yield today?

Over the past month, Ascendis Pharma (ASND) has returned -9.33% — 27.67% over the past year, and 63.12% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Ascendis Pharma (ASND) today at the current price of $ 218.06 your total investment would be $ 21,806.00.

Based on historical performance, the investment would have grown to approximately:

$ 27,839.72 after 1 year
$ 35,569.95 after 5 years
$ 340,374.22 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ASND

Ascendis Pharma A/S

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ASND

review the fundamentals of Ascendis Pharma shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Ascendis Pharma

Ascendis Pharma A/S

United States

20 years

2015

482

PROFIT X PRICE ASND

Financial Results ASND

ASND cash flow

Asset, Revenue and Profit Growth - ASND

ASND balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

Frequently Asked Questions